Longevitix

About

Funding history · 1 round · $3.5M total

Q&A

What is Longevitix's primary business?

Longevitix operates an AI-powered clinical intelligence platform designed for preventive and longevity medicine. It unifies and analyzes fragmented patient data to provide physicians with insights, personalized intervention plans, and continuous care support.

When was Longevitix founded?

Longevitix was founded in 2025.

Who are the founders of Longevitix?

The co-founders of Longevitix are Effie Arditi (CEO), Gaby Hayon (CTO), and Dr. Neil Panchal (Chief Medical Officer).

What is Longevitix's current employee count?

As of August 2026, Longevitix has 5 employees.

Which investors participated in Longevitix's Pre-Seed funding round?

In February 2026, Longevitix secured Pre-Seed funding from investors including Fresh.Fund and Good Company (Israel).

What types of customers does Longevitix target?

Longevitix targets longevity clinics, functional medicine clinics, concierge practices, integrative medicine practices, med spas, and direct primary care providers.

What is Longevitix's primary sector and key technologies?

Longevitix's primary sector is Health Tech & Life Sciences, utilizing AI and Machine Learning as its core technologies.

Where is Longevitix headquartered?

Longevitix is headquartered in Tel Aviv, Israel.

Team · 8

Effie Arditi

Founder · Co-Founder & CEO

Gaby Hayon

Founder · Co-Founder & CTO

Dr. Neil Panchal

Founder · Co-Founder & Chief Medical Officer

Doron Feldman

VP Engineering

Zachy Hershkovich

VP R&D

Renana Sabi

Head of product

Tamar Rucham

Senior Full Stack Eng

Sivan Ebril

Medical Director

Sectors & technology